We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Off-Label Warnings Hindering Development of New Indications
Off-Label Warnings Hindering Development of New Indications
May 21, 2010
A rash of warning letters the FDA has sent devicemakers for off-label promotion has industry concerned about the deepening lack of flexibility to develop new uses for devices.